Hasil Pencarian - Mark D Pegram

  • Menampilkan 1 - 5 hasil dari 5
Perbaiki Hasil
  1. 1
    Single-cell immunoblotting resolves estrogen receptor-α isoforms in breast cancer.

    Single-cell immunoblotting resolves estrogen receptor-α isoforms in breast cancer. oleh John J Kim, Wenchuan Liang, Chi-Chih Kang, Mark D Pegram, Amy E Herr

    Diterbitkan 2021-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Role of Fcγ receptors in HER2-targeted breast cancer therapy

    Role of Fcγ receptors in HER2-targeted breast cancer therapy oleh Hope S Rugo, Antonino Musolino, William J Gradishar, Jeffrey L Nordstrom, Edwin P Rock, Fernanda Arnaldez, Mark D Pegram

    Diterbitkan 2022-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Rapid Reduction in Breast Cancer Mortality With Inorganic Arsenic in Drinking Water

    Rapid Reduction in Breast Cancer Mortality With Inorganic Arsenic in Drinking Water oleh Allan H. Smith, Guillermo Marshall, Yan Yuan, Craig Steinmaus, Jane Liaw, Martyn T. Smith, Lily Wood, Marissa Heirich, Rebecca M. Fritzemeier, Mark D. Pegram, Catterina Ferreccio

    Diterbitkan 2014-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Clinical validation of an immunohistochemistry‐based CanAssist‐Breast test for distant recurrence prediction in hormone receptor‐positive breast cancer patients

    Clinical validation of an immunohistochemistry‐based CanAssist‐Breast test for distant recurrence prediction in hormone receptor‐positive breast cancer patients oleh Manjiri M. Bakre, Charusheila Ramkumar, Arun Kumar Attuluri, Chetana Basavaraj, Chandra Prakash, Ljubomir Buturovic, Lekshmi Madhav, Nirupama Naidu, Prathima R, S. P. Somashekhar, Sudeep Gupta, Dinesh Chandra Doval, Mark D. Pegram

    Diterbitkan 2019-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    716 Phase 2 study of the HER2-targeting TLR7/8 immune stimulating antibody conjugate (ISAC) BDC-1001 monotherapy +/- nivolumab in patients with HER2+ colorectal, endometrial, or gastroesophageal cancer

    716 Phase 2 study of the HER2-targeting TLR7/8 immune stimulating antibody conjugate (ISAC) BDC-1001 monotherapy +/- nivolumab in patients with HER2+ colorectal, endometrial, or ga... oleh Jean-Yves Blay, Antoine Italiano, Stephane Champiat, Paolo Antonio Ascierto, Manish Sharma, Jeeyun Lee, Luis Paz-Ares Rodriguez, Keun-Wook Lee, Yoon-Koo Kang, Drew Rasco, Edith A Perez, Mariano Ponz-Sarvise, Lu Xu, Jean-Philippe Spano, Coya Tapia, Ecaterina Dumbrava, Kathleen Moore, Jason Ptacek, Michele Magni, Alfonso Cortes Salgado, Ming Yin, Agnese Losurdo, Antoine Deleuze, Mark D Pegram, Ardaman Shergill, Alexander I Spira, Michael N Alonso, Joan Albanell Mestres, Marta GilMartin, Arielle Heeke, Ana Oaknin Benzaquen, Ignacio Ortego Zabalza, Haeseong Park, Cecile Vicier, Ivan Victoria, Benjamin Weinberg, Bob T Li

    Diterbitkan 2023-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: